Synlogic

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Synlogic and other ETFs, options, and stocks.

About SYBX

Synlogic, Inc. is a biopharmaceutical company which engages in the discovery and development of synthetic biotic medicines. It focuses on phenylketonuria, enteric hyperoxaluria, immuno-oncology solid tumors, inflammatory bowel disease, and vaccines and other inflammatory programs. 

CEO
Mary Beth Dooley
CEOMary Beth Dooley
Employees
1
Employees1
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
2007
Founded2007
Employees
1
Employees1

SYBX Key Statistics

Market cap
7.84M
Market cap7.84M
Price-Earnings ratio
-4.22
Price-Earnings ratio-4.22
Dividend yield
Dividend yield
Average volume
13.25K
Average volume13.25K
High today
$1.06
High today$1.06
Low today
$0.65
Low today$0.65
Open price
$0.7768
Open price$0.7768
Volume
1.60M
Volume1.60M
52 Week high
$1.96
52 Week high$1.96
52 Week low
$0.65
52 Week low$0.65

Stock Snapshot

As of today, Synlogic(SYBX) shares are valued at $0.67. The company's market cap stands at 7.84M, with a P/E ratio of -4.22.

On 2026-01-20, Synlogic(SYBX) stock traded between a low of $0.65 and a high of $1.06. Shares are currently priced at $0.67, which is +3.1% above the low and -36.8% below the high.

Synlogic(SYBX) shares are trading with a volume of 1.6M, against a daily average of 13.25K.

During the past year, Synlogic(SYBX) stock moved between $0.65 at its lowest and $1.96 at its peak.

During the past year, Synlogic(SYBX) stock moved between $0.65 at its lowest and $1.96 at its peak.

People also own

Based on the portfolios of people who own SYBX. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the .